Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleAnti‐CD19 chimeric antigen receptor‐modified T‐cell therapy bridging to allogeneic hematopoietic stem cell transplantation for relapsed/refractory B‐cell acute lymphoblastic leukemia: An open‐label pragmatic clinical trial.AuthorsJiang, Huiwen; Li, Chenggong; Yin, Ping; Guo, Tao; Liu, Lin; Xia, Linghui; Wu, Yaohui; Zhou, Fen; Ai, Lisha; Shi, Wei; Lu, Xuan; Wang, Huafang; Tang, Lu; Wei, Qiuzhe; Deng, Jun; Jin, Runming; Xiong, Wei; Dong, Jian; Mei, Heng; Hu, YuPublicationAmerican Journal of Hematology, 2019, Vol 94, Issue 10, p1113ISSN0361-8609Publication typeArticleDOI10.1002/ajh.25582